Blood conservation in patients undergoing non-cardiac surgery

Current Opinion in Anaesthesiology

Volumn 13, Issue 3, 2000, Pages 365-370

  Goodnough, Lawrence T ^a   Monk, Terri G ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; ERYTHROPOIETIN; HEMOGLOBIN DERIVATIVE; IRON; PERFLUOROOCTYL BROMIDE;

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BLOOD SUBSTITUTION; ERYTHROCYTE; HEALTH CARE COST; HEMODILUTION; HUMAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SAFETY; SURGICAL PATIENT; TECHNIQUE;

EID: 0034040905     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200006000-00023     Document Type: Article

References (55)

1. 1 Goodnough LT, Monk TG, Brecher ME. Autologous blood procurement in the surgical setting: lessons learned in the last 10 years. Vox Sang 1996; 71:133-141.
2. 2 Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Medical progress: transfusion medicine. Part I. Blood transfusion. N Engl J Med 1999; 340;438-447. An excellent review of the risks and indications for red blood cell transfusions.
3. 3 Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Medical progress: transfusion medicine. Part II. Blood conservation. N Engl J Med 1999; 340:525-533. An excellent review of the present state of autologous blood conservation practices.
4. 4 Toy PTCY, Strauss RG, Stehling LC, Sears R, Price TH, Rossi EC, et al. Predeposited autologous blood for elective surgery: a national multicenter study. N Engl J Med 1987; 316:517-520.
5. 5 Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, et al. The cost-effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332:719-724.
6. 6 Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals. Arch Pathol Lab Med 1992; 116:613-619.
7. 7 Yomtovian R, Kruskall MS, Barber JP. Autologous-blood transfusion: the reimbursement dilemma. J Bone Joint Surg 1992; 74A: 1265-1272.
8. 8 Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having total hip or knee arthroplasty. J Bone Joint Surg 1999; 81:2-10. A review describing the current practice of preoperative autologous blood donation in orthopedic surgery.
9. 9 Linden JV, Kruskall MS. Autologous blood: always safer? Transfusion 1997; 37:455-456.
10. 10 Goldman M, Rémy-Prince S, Trépanier A, Decary F. Autologous donation error rates in Canada. Transfusion 1997; 37:523-527.
11. 11 Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donations: frequency and characterization. Transfusion 1995; 35:734-737.
12. 12 Goodnough LT, Monk TG. Evolving concepts in autologous blood procurement. Case reports of perisurgical anemia complicated by myocardial infarction. Amer J Med 1996; 101:12A-33S.
13. 13 Kasper SM, Ellering J, Stachwitz P, Lynch J, Grunenberg R, Buzello W. All adverse events in autologous blood donors with cardiac disease are not necessarily caused by donation. Transfusion 1998; 38:669-673. A case report describing life-threatening cardiac events in autologous blood donors.
14. 14 Kanter MH, van Maanen D, Anders KH, Castro F, Mya WW, Clark K. Perioperative autologous blood donations before elective hysterectomy. JAMA 1996; 276:798-801.
15. 15 Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91:24-33. A prospective study comparing the benefits and limitations of preoperative autologous blood donation, ANH, and presurgical erythropoietin therapy.
16. 16 Heiss MM, Mempel W, Delanoff C, Jauch KW, Ganka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12:1859-1867.
17. 17 Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328:1372-1376.
18. 18 Goodnough LT, Price TH, Parvin CA. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender. J Lab Clin Med 1995; 125:57-64.
19. 19 Goodnough LT, Marcus RE. Erythropoiesis in patients stimulated with erythopoietin: the relevance of storage iron. Vox Sang 1998; 75:128-133.
20. 20 Consensus conference on autologous transfusion. Final consensus statement. Transfusion 1996; 36:667.
21. 21 British Committee for Standards in Hematology. Blood transfusion task force: guidelines for autologous transfusion. Transfusion Med 1993; 3:307-316.
22. 22 Larocque BJ, Gilbert K, Brien WF. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion 1997; 37:463-467.
23. 23 Larocque BJ, Gilbert K, Brien WF. Prospective validation of a point score system for predicting blood transfusion following hip or knee replacement. Transfusion 1998; 38:932-937. This manuscript describes a point score system that can be applied in clinical practice to predict the likelihood of a perioperative blood transfusion after hip or knee replacement.
24. 24 Goodnough LT, Skikne B, Brugnora C. Erythropoietin, iron and erythropoiesis. Blood 2000; in press.
25. 25 Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative human erythropoietin in elective hip replacement. Lancet 1993; 341:1227-1232.
26. 26 Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med 1997; 336:933-938.
27. 27 Stowell CP, Chandler H, Jové M, Guilfoyle M, Wacholtz MC. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 1999; 22:S105-S112. A prospective, randomized trial demonstrating that presurgical erythropoietin therapy can replace PAD in total joint arthroplasty.
28. 28 Goodnough LT, Grishaber JE, Monk TG, Catalona WJ. Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy. Anest Analg 1994; 78:932-937.
29. 29 Monk TG, Goodnough LT, Brecher ME, Pulley DD, Colberg JW, Andriole GL, Catalona WJ. Acute normovolemic hemodilution can replace preoperative autologous donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg 1997; 85:953-958.
30. 30 Goodnough LT, Brecher ME, Monk TG. Acute normovolemic hemodilution in surgery. Hematology 1997; 2:413-420.
31. 31 Brecher ME, Monk TG, Goodnough LT. A standardized method for the calculation of blood loss. Transfusion 1997; 37:1070-1074.
32. 32 Goodnough LT, Grishaber JE, Birkmeyer JD, Monk TG, Catalona WJ. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 1994; 44:226-231.
33. 33 Toy PTCY, Menozzi D, Strauss RG, Stehling LC, Kruskall M, Ahn DK. Efficacy of preoperative donation of blood for autologous use in radical prostatectomy. Transfusion 1993; 33:721-724.
34. 34 Toy PTCY, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC. Blood loss and replacement in total hip arthroplasty: a multicenter study. Transfusion 1992; 32:63-67.
35. 35 Goodnough LT, Shafron D, Marcus RE. The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang 1990; 59:65-69.
36. 36 Goodnough LT, Monk TG, Despoils GJ, Merkel K. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999; 77:11-16. A prospective study evaluating the use of ANH for total knee arthroplasy.
37. 37 Goodnough LT, Despotis GJ, Merkel K, Monk TG. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total hip arthroplasty. Transfusion 2000; in press.
38. 38 Roberts WA, Kirkley SA, Newby M. A cost comparison of allogeneic and preoperatively or intraoperatively donated blood. Anesth Analg 1996; 83:129-133.
39. 39 Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion 1991; 31:662-675.
40. 40 Napier JA, Bruce M, Chapman J, Duguid JKM, Kelsey PR, Knowles SM, et al. Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. Br J Anaesth 1997; 78:768-771.
41. 41 Clagett GP, Valentine RJ, Jackson MR, Mathison C, Kakish HB, Bengtson TD. A randomized trial of intraoperative autotransfusion during aortic surgery. J Vasc Surg 1999; 29:22-31. A prospective clinical trial evaluating the efficacy of intraoperative autotransfusions at preventing allogeneic transfusion in aortic surgery.
42. 42 Linden JV, Tourault MA, Scribner CL. Decrease in frequency of transfusion fatalities. Transfusion 1997; 37:243-244.
43. 43 Goodnough LT, Monk TG, Sicard G, Satterfield SA, Martin K, Allen B, et al. Intraoperative salvage in patients undergoing elective abdominal aortic aneurism repair. An analysis of costs and benefits. J Vasc Surg 1996; 24:213-218.
44. 44 Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB. Salvage and reinfusion of postoperative sanguineous wound drainage. J Bone Joint Surg 1992; 74A.-646-651.
45. 45 Woda R, Tetzlaff JE. Upper airway oedema following autologous blood transfusion from a wound drainage system. Can J Anaesth 1992; 39:290-292.
46. 46 Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after knee and hip arthroplasties. J Bone Joint Surg 1991; 73A:1169-1177.
47. 47 Ritter MA, Keating EM, Faris PM. Closed wound drainage in total hip or total knee replacement. J Bone Surg 1994; 76:35-38.
48. 48 Umlas J, Foster RR, Dalal SA, O'Leary SM, Garcia L, Kruskall MS. Red cell loss following orthopedic surgery: the case against postoperative blood salvage. Transfusion 1994; 34:402-406.
49. 49 Winslow RM. Blood substitutes - a moving target. Nat Med 1995; 1:1212-1215.
50. 50 Scott MG, Kucik DF, Goodnough LT, Monk TG. Blood substitutes: evolution and future applications. Clin Chem 1997; 43:1724-1731.
51. 51 Ma Z, Monk TG, Goodnough LT, McClellan A, Gawryl M, Clark T, et al. Effect of hemoglobin-and perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem 1997; 43:1732-1737.
52. 52 Kasper SM, Grune F, Walter M, Amr N, Erasmi H, Buzello W. The effects of increased doses of bovine hemoglobin on hemodynamic and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87:284-291. This manuscript describes the vasoactive effects of hemoglobin-based oxygen-carrying solutions and the negative impact of these effects on oxygen delivery.
53. 53 Loscalzo J. Nitric oxide binding and the adverse effects of cell-free hemoglobins: what makes us different from earth worms? J Lab Clin Med 1997; 129:580-583.
54. 54 Brecher ME, Goodnough LT, Monk T. The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling. Transfusion 1999; 39:396-402. A paper discussing the blood conservation benefits of oxygen-carrying solutions alone or combined with ANH.
55. 55 Spahn DR, van Brempt R, Theilmeier G, Reibold JP, Welte M, Heinzerling H, et al. Perflubron emulsion delays transfusions in orthopedic surgery. Anesthesiology 1999; 91:1195-1208. A recent prospective study describing the efficacy of perflubron in reversing physiological transfusion triggers.